Fingerprint
Dive into the research topics of 'Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: A phase 2 trial in the North Central Cancer Treatment Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: A phase 2 trial in the North Central Cancer Treatment Group
Stephen M. Ansell, David J. Inwards, Kendrith M. Rowland, Patrick J. Flynn, Roscoe F. Morton, Dennis F. Moore, Scott H. Kaufmann, Irene Ghobrial, Paul J. Kurtin, Matthew Maurer, Christine Allmer, Thomas E. Witzig
Research output: Contribution to journal › Article › peer-review
184
Scopus
citations